Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 132, Issue 1, Pages 131-142
Publisher
Springer Nature
Online
2011-05-14
DOI
10.1007/s10549-011-1529-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How to Train Your Biomarker
- (2010) D. Yee CLINICAL CANCER RESEARCH
- Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development
- (2010) T. M. Pitts et al. CLINICAL CANCER RESEARCH
- Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines
- (2009) Ashok K. Chakraborty et al. BREAST CANCER RESEARCH AND TREATMENT
- Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma
- (2009) Alessandra Capodanno et al. HUMAN PATHOLOGY
- Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas
- (2009) Charpin INTERNATIONAL JOURNAL OF ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells
- (2008) A. Esparis-Ogando et al. ANNALS OF ONCOLOGY
- GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value
- (2008) D. Voduc et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Impact of inbreeding on fertility in a pre-industrial population
- (2008) Alexandre Robert et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
- (2008) John SP Yuen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients
- (2008) Troy M. Bremer et al. INTERNATIONAL JOURNAL OF CANCER
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
- (2008) Quanri Jin et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
- (2008) S. John Weroha et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed
- (2008) Krista A. Power et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924
- (2008) P. Haluska et al. MOLECULAR CANCER THERAPEUTICS
- Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
- (2008) Y. Shang et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started